Skip to content

CLINICAL OUTCOMES OF DIFFERENT MULTIFOCAL TORIC IOLs IN ONE YEAR PROSPECTIVE CLINICAL STUDY

Safety,efficacy and rotational stability of different Multifocal Toric IOLs -One Year Prospective controlled clinical study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021676
Enrollment
64
Registered
2019-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: Eyecryl ACTV Diffractive Multifocal IOL: The safety and effectiveness of Eyecryl ACTV diffractive Multifocal IOL and TECNIS Multifocal Toric IOLs implanted to replace the natural lens i

Sponsors

Dr Sri Ganesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who has been implanted bilaterally with the Multifocal Toric IOL will be included in the Study. 2. Age 18 and older 3. Regular corneal topography and corneal astigmatism more than 0.75 D. 4. Best Corrected Visual Acuity to be 0.2 LogMAR or Lower 5. Clear intraocular media 6. Availability, willingness and sufficient cognitive awareness to comply with examination procedures 7. Patients who has given informed written consent.

Exclusion criteria

Exclusion criteria: 1. Any active ocular disease (Diabetic retinopathy, macular degeneration, glaucoma with field defects and irregular corneal astigmatism) 2. Previous intraocular and corneal surgery 3. Pregnancy & Lactation 4. Traumatic Cataract 5. Subject who are expected to required retinal laser treatment Concurrent participation in another drug or device Study.

Design outcomes

Primary

MeasureTime frame
Visual acuity (UCDVA & BCDVA).Visual acuity (Near & Intermediate).Toric Marks Measurement (Rotational Stability) using Itrace.Refractive astigmatism.Spherical EquivalentTimepoint: Preoperative Visit.Intraoperative Visit.Postoperative 1 Day.Postoperative 7 Days.Postoperative 30 Days.Postoperative 90 Days.Postoperative 180 Days.Postoperative 365 Days

Secondary

MeasureTime frame
Intraocular Pressure (IOP).Endothelial Cell Count.Pupil Size.Defocus CurveCorrected up to ± 4 D.Timepoint: Preoperative Visit.Intraoperative Visit.Postoperative 1 Day.Postoperative 7 Days.Postoperative 30 Days.Postoperative 90 Days.Postoperative 180 Days.Postoperative 365 Days

Countries

India

Contacts

Public ContactDr Sri Ganesh

Nethradhama Super Speciality Eye Hospital

phacomaverick@gmail.com9845129740

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026